JP2002537264A - ベンズアルデヒド誘導体 - Google Patents
ベンズアルデヒド誘導体Info
- Publication number
- JP2002537264A JP2002537264A JP2000599401A JP2000599401A JP2002537264A JP 2002537264 A JP2002537264 A JP 2002537264A JP 2000599401 A JP2000599401 A JP 2000599401A JP 2000599401 A JP2000599401 A JP 2000599401A JP 2002537264 A JP2002537264 A JP 2002537264A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cells
- cancer
- cell
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO990814A NO309305B1 (no) | 1999-02-19 | 1999-02-19 | Anvendelse av benzaldehydderivater ved fremstilling av farmasöytiske preparater for forebygging og/eller behandling av kreft, samt visse nye benzaldehydderivater |
NO19990814 | 1999-02-19 | ||
PCT/NO2000/000060 WO2000048610A1 (en) | 1999-02-19 | 2000-02-18 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2002537264A true JP2002537264A (ja) | 2002-11-05 |
Family
ID=19902986
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000599400A Pending JP2002537263A (ja) | 1999-02-19 | 2000-02-18 | 化学物質 |
JP2000599401A Pending JP2002537264A (ja) | 1999-02-19 | 2000-02-18 | ベンズアルデヒド誘導体 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000599400A Pending JP2002537263A (ja) | 1999-02-19 | 2000-02-18 | 化学物質 |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP1150690A1 (pt) |
JP (2) | JP2002537263A (pt) |
CN (2) | CN1347323A (pt) |
AU (2) | AU2834200A (pt) |
BR (2) | BR0008302A (pt) |
CA (2) | CA2362306A1 (pt) |
CZ (2) | CZ20012965A3 (pt) |
HU (2) | HUP0105281A2 (pt) |
IL (2) | IL144895A0 (pt) |
MX (2) | MXPA01008346A (pt) |
NO (1) | NO309305B1 (pt) |
PL (2) | PL350519A1 (pt) |
RU (2) | RU2001123035A (pt) |
SK (2) | SK11602001A3 (pt) |
WO (2) | WO2000048609A1 (pt) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011516478A (ja) * | 2008-04-03 | 2011-05-26 | コグネイト 3,エルエルシー | 免疫療法のための組成物および方法 |
JP2015178537A (ja) * | 2002-12-19 | 2015-10-08 | インファール・アクティエンゲゼルシャフト | 重水素化カテコールアミン誘導体ならびにそれらの化合物を含有する医薬品 |
JP2017509686A (ja) * | 2014-04-04 | 2017-04-06 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002096921A1 (fr) * | 2001-05-30 | 2002-12-05 | Nisshin Seifun Group Inc. | Nouveau derive glucose induisant l'apoptose, procede de production et utilisation comme medicament |
CN102134232B (zh) * | 2005-07-26 | 2012-11-21 | 奈科明有限责任公司 | 同位素取代的质子泵抑制剂 |
AR054583A1 (es) * | 2005-07-26 | 2007-06-27 | Altana Pharma Ag | Pantoprazol isotopicamente sustituido |
WO2007041630A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties |
CN101157711B (zh) * | 2007-09-28 | 2010-12-08 | 西安交通大学 | 一种具有抗肿瘤活性的化合物及其用途 |
CN101735284B (zh) * | 2008-11-24 | 2012-05-23 | 上海医药工业研究院 | 一种4,6-o-苄叉-d-吡喃葡萄糖的制备方法 |
CN114366741A (zh) | 2013-12-03 | 2022-04-19 | 细胞内治疗公司 | 新方法 |
JP6898072B2 (ja) * | 2015-08-27 | 2021-07-07 | 秀行 佐谷 | 14−3−3タンパク質活性調節剤 |
ES2879888T3 (es) | 2016-03-25 | 2021-11-23 | Intra Cellular Therapies Inc | Compuestos orgánicos y su uso en el tratamiento o prevención de trastornos del sistema nervioso central |
JP7013454B2 (ja) | 2016-10-12 | 2022-02-15 | イントラ-セルラー・セラピーズ・インコーポレイテッド | アモルファス固体分散体 |
BR112019019875A2 (pt) | 2017-03-24 | 2020-04-22 | Intra Cellular Therapies Inc | novas composições e métodos |
BR112021003655A2 (pt) | 2018-08-31 | 2021-05-18 | Intra-Cellular Therapies, Inc. | métodos novos |
US10695345B2 (en) | 2018-08-31 | 2020-06-30 | Intra-Cellular Therapies, Inc. | Pharmaceutical capsule compositions comprising lumateperone mono-tosylate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB811510A (en) * | 1954-12-20 | 1959-04-08 | Gyogyszeripari Ki | New nitrogen-containing derivatives of polyhydroxy compounds and process for the preparation thereof |
JPS6112623A (ja) * | 1984-06-28 | 1986-01-21 | Kaken Pharmaceut Co Ltd | エンケフアリナ−ゼ阻害剤 |
JPS6256423A (ja) * | 1985-09-06 | 1987-03-12 | Kaken Pharmaceut Co Ltd | 悪液質治療改善剤 |
GB8705780D0 (en) * | 1987-03-11 | 1987-04-15 | Norsk Hydro As | Anticancer compounds |
JPH07145191A (ja) * | 1993-11-24 | 1995-06-06 | Japan Tobacco Inc | ガラクトシルホスフォネート誘導体 |
-
1999
- 1999-02-19 NO NO990814A patent/NO309305B1/no not_active IP Right Cessation
-
2000
- 2000-02-18 RU RU2001123035/14A patent/RU2001123035A/ru unknown
- 2000-02-18 AU AU28342/00A patent/AU2834200A/en not_active Abandoned
- 2000-02-18 JP JP2000599400A patent/JP2002537263A/ja active Pending
- 2000-02-18 CA CA002362306A patent/CA2362306A1/en not_active Abandoned
- 2000-02-18 CN CN00806488A patent/CN1347323A/zh active Pending
- 2000-02-18 EP EP00906782A patent/EP1150690A1/en not_active Withdrawn
- 2000-02-18 CN CN00806338A patent/CN1347322A/zh active Pending
- 2000-02-18 PL PL00350519A patent/PL350519A1/xx not_active Application Discontinuation
- 2000-02-18 JP JP2000599401A patent/JP2002537264A/ja active Pending
- 2000-02-18 MX MXPA01008346A patent/MXPA01008346A/es not_active Application Discontinuation
- 2000-02-18 CZ CZ20012965A patent/CZ20012965A3/cs unknown
- 2000-02-18 RU RU2001123124/15A patent/RU2001123124A/ru unknown
- 2000-02-18 IL IL14489500A patent/IL144895A0/xx unknown
- 2000-02-18 PL PL00350520A patent/PL350520A1/xx not_active Application Discontinuation
- 2000-02-18 BR BR0008302-0A patent/BR0008302A/pt not_active Application Discontinuation
- 2000-02-18 MX MXPA01008347A patent/MXPA01008347A/es not_active Application Discontinuation
- 2000-02-18 HU HU0105281A patent/HUP0105281A2/hu unknown
- 2000-02-18 WO PCT/NO2000/000059 patent/WO2000048609A1/en not_active Application Discontinuation
- 2000-02-18 WO PCT/NO2000/000060 patent/WO2000048610A1/en not_active Application Discontinuation
- 2000-02-18 HU HU0105280A patent/HUP0105280A2/hu unknown
- 2000-02-18 AU AU28341/00A patent/AU2834100A/en not_active Abandoned
- 2000-02-18 BR BR0008297-0A patent/BR0008297A/pt not_active Application Discontinuation
- 2000-02-18 CZ CZ20012966A patent/CZ20012966A3/cs unknown
- 2000-02-18 SK SK1160-2001A patent/SK11602001A3/sk unknown
- 2000-02-18 IL IL14489600A patent/IL144896A0/xx unknown
- 2000-02-18 EP EP00906781A patent/EP1150689A1/en not_active Withdrawn
- 2000-02-18 CA CA002363670A patent/CA2363670A1/en not_active Abandoned
- 2000-02-18 SK SK1161-2001A patent/SK11612001A3/sk unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015178537A (ja) * | 2002-12-19 | 2015-10-08 | インファール・アクティエンゲゼルシャフト | 重水素化カテコールアミン誘導体ならびにそれらの化合物を含有する医薬品 |
JP2011516478A (ja) * | 2008-04-03 | 2011-05-26 | コグネイト 3,エルエルシー | 免疫療法のための組成物および方法 |
JP2017509686A (ja) * | 2014-04-04 | 2017-04-06 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
JP2020079231A (ja) * | 2014-04-04 | 2020-05-28 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
Also Published As
Publication number | Publication date |
---|---|
HUP0105280A2 (hu) | 2002-04-29 |
JP2002537263A (ja) | 2002-11-05 |
NO990814D0 (no) | 1999-02-19 |
NO309305B1 (no) | 2001-01-15 |
IL144895A0 (en) | 2002-06-30 |
MXPA01008346A (es) | 2003-06-06 |
RU2001123124A (ru) | 2004-02-20 |
CA2363670A1 (en) | 2000-08-24 |
CN1347323A (zh) | 2002-05-01 |
MXPA01008347A (es) | 2004-03-10 |
PL350519A1 (en) | 2002-12-16 |
IL144896A0 (en) | 2002-06-30 |
WO2000048610A1 (en) | 2000-08-24 |
CN1347322A (zh) | 2002-05-01 |
CA2362306A1 (en) | 2000-08-24 |
AU2834200A (en) | 2000-09-04 |
WO2000048609A1 (en) | 2000-08-24 |
HUP0105281A2 (hu) | 2002-05-29 |
AU2834100A (en) | 2000-09-04 |
RU2001123035A (ru) | 2004-03-20 |
NO990814L (no) | 2000-08-21 |
CZ20012965A3 (cs) | 2002-03-13 |
PL350520A1 (en) | 2002-12-16 |
BR0008302A (pt) | 2002-08-27 |
SK11612001A3 (sk) | 2002-04-04 |
CZ20012966A3 (cs) | 2002-03-13 |
SK11602001A3 (sk) | 2002-02-05 |
EP1150690A1 (en) | 2001-11-07 |
BR0008297A (pt) | 2002-05-28 |
EP1150689A1 (en) | 2001-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2002537264A (ja) | ベンズアルデヒド誘導体 | |
EP0196415B1 (en) | Trichostatins a and c as antitumour drugs | |
AU2010241807B2 (en) | Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors | |
JPH09511233A (ja) | 細胞接着インヒビターとしての置換ラクトース誘導体 | |
EP0283139A2 (en) | Anticancer compounds | |
WO1997000881A1 (en) | Moranoline derivatives | |
US9833508B2 (en) | Cancer therapeutics | |
WO2005103064A1 (ja) | 新規糖鎖担持カルボシランデンドリマー | |
EP3928835B1 (en) | Water-soluble polymeric derivative of venetoclax | |
JP3193061B2 (ja) | 天然型抗腫瘍性又は抗ウイルス性物質およびその用途 | |
KR20010113695A (ko) | 화합물 | |
NZ502247A (en) | 13-deoxyanthracycline derivatives and processes for preparing them | |
JP2001131066A (ja) | アポトーシス増強剤 | |
KR100398289B1 (ko) | 신규 안트라사이클린 유도체 및 그 제조방법 | |
NO312226B1 (no) | Anvendelse av 4,6-<Omikron>-(benzyliden-d1)-D-glukopyranose og den tilsvarende 1-isomer ved profylakse og behandling av kreft | |
EP1198467A1 (en) | 5-nitrofurfural derivatives | |
CN106995368B (zh) | 一种非atp竞争性fgfr1抑制剂及其应用 | |
JP4143169B2 (ja) | ノジリマイシン亜硫酸付加物のアシル化物 | |
JP2004256463A (ja) | 多形核白血球の細胞接着抑制剤及び細胞接着抑制方法 | |
JPH11269065A (ja) | 癌細胞のアポトーシス耐性の克服剤 | |
JP3660230B2 (ja) | 天然型抗腫瘍性又は抗ウイルス性物質およびその用途 | |
JP6281901B2 (ja) | 水溶性ポルフィリン誘導体とそれらの製造方法 | |
JP4246358B2 (ja) | ポリエンマクロライド系抗生物質の多量体 | |
CN116731091A (zh) | 具有脂肪酶抑制活性的酰基他定类化合物、其制备方法及应用 | |
TW201247208A (en) | A pharmaceutical composition for inhibiting the recurrence, progression or metastasis of liver cancer |